Congratulations! You now have unlimited access to all articles from The Medicine Maker.
Complete your profile at your earliest convenience to unlock the rest of your benefits:
relevant and personalised updates about your field
access to White Papers/product profiles
digital magazine subscription
The Medicine Maker
This issue, we warm up for our upcoming 2022 Innovation Awards with a look back at 2021’s Grand Winner and two runners up: a software system, a new form of smart connector, and new equipment for analytical science. Within its pages you’ll also find a cell and gene expert weighing the pros and cons of LLV and AAV viral vectors, and the new head of the Drugs for Neglected Diseases initiative explaining why we need to decolonize drug development. Further politically-minded commentary is on offer in an opinion piece arguing that pharma needs a disruptive “Elon Musk” figure to turn the field on its head.